Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner.
Zhang, Qian; Wang, Hong Yi; Wei, Fang; Liu, Xiaobin; Paterson, Jennifer C; Roy, Darshan; Mihova, Daniela; Woetmann, Anders; Ptasznik, Andrzej; Odum, Niels; Schuster, Stephen J; Marafioti, Teresa; Riley, James L; Wasik, Mariusz A.
; 192(6): 2913-9, 2014 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-24523507
Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma.
Expression of programmed death-1 in cutaneous extranodal natural killer/T-cell lymphoma and its effect on clinical findings and biological behaviour.
Brentuximab vedotin therapy for CD30-positive cutaneous T-cell lymphoma: a targeted approach to management.
STAT5 induces miR-21 expression in cutaneous T cell lymphoma.
Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells.
TOX expression and role in CTCL.
Genomic landscape of cutaneous T cell lymphoma.
Primary Cutaneous T-cell Lymphoma With Aberrant CD-20 Expression.
KIR3DL2 expression in cutaneous T-cell lymphomas: expanding the spectrum for KIR3DL2 targeting.
IL-13 as a novel growth factor in CTCL.